FMR LLC 13D and 13G filings for Blueprint Medicines Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-12 09:16 am Sale |
2024-12-31 | 13G | Blueprint Medicines Corporation BPMC |
FMR LLC | 2,247,679 3.500% |
-2,100,632 (-48.31%) |
Filing |
| 2024-02-09 08:35 am Sale |
2024-02-08 | 13G | Blueprint Medicines Corporation BPMC |
FMR LLC | 4,348,311 7.153% |
-324,800 (-6.95%) |
Filing |
| 2023-11-13 09:02 am Sale |
2023-11-10 | 13G | Blueprint Medicines Corporation BPMC |
FMR LLC | 4,673,111 7.687% |
-4,301,434 (-47.93%) |
Filing |
| 2023-02-09 08:23 am Purchase |
2023-02-09 | 13G | Blueprint Medicines Corporation BPMC |
FMR LLC | 8,974,545 14.999% |
2,941,866 (+48.77%) |
Filing |
| 2022-05-10 10:13 am Purchase |
2022-05-09 | 13G | Blueprint Medicines Corporation BPMC |
FMR LLC | 6,032,679 10.126% |
3,684,227 (+156.88%) |
Filing |
| 2022-02-09 09:09 am Sale |
2022-02-08 | 13G | Blueprint Medicines Corporation BPMC |
FMR LLC | 2,348,452 3.991% |
-1,841,923 (-43.96%) |
Filing |
| 2021-02-08 10:17 am Sale |
2021-02-05 | 13G | Blueprint Medicines Corporation BPMC |
FMR LLC | 4,190,375 7.518% |
-917,344 (-17.96%) |
Filing |